These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32340978)

  • 21. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis
    Schulze-Koops H; Krueger K; Specker C
    Ann Rheum Dis; 2021 Apr; 80(4):e61. PubMed ID: 32475833
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
    Dejaco C; Alunno A; Bijlsma JW; Boonen A; Combe B; Finckh A; Machado PM; Padjen I; Sivera F; Stamm TA; Buttgereit F
    Ann Rheum Dis; 2021 Apr; 80(4):518-526. PubMed ID: 33158877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?].
    Braunisch MC; Bachmann Q; Hammitzsch A; Lorenz G; Geisler F; Schmaderer C; Heemann U; Moog P
    Z Rheumatol; 2021 Jun; 80(5):408-417. PubMed ID: 33258019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.
    Haberman RH; Jaros BD; Scher JU
    Curr Opin Rheumatol; 2021 Sep; 33(5):409-411. PubMed ID: 34175865
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America.
    Fernández-Ávila DG; Barahona-Correa J; Romero-Alvernia D; Kowalski S; Sapag A; Cachafeiro-Vilar A; Meléndez B; Pastelín C; Palleiro D; Arrieta D; Reyes G; Pons-Estel GJ; Then-Báez J; Ugarte-Gil MF; Cardiel MH; Colman N; Chávez N; Burgos PI; Montufar R; Sandino S; Fuentes-Silva YJ; Soriano ER
    Rheumatol Int; 2022 Jan; 42(1):41-49. PubMed ID: 34739574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rheumatology update 2020: the focus was on Covid-19].
    Hügle T
    Rev Med Suisse; 2021 Jan; 17(723):214-218. PubMed ID: 33507664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice.
    Yazdany J; Shiboski S; Schmajuk G
    Arthritis Rheumatol; 2024 Oct; 76(10):1467-1470. PubMed ID: 38923852
    [No Abstract]   [Full Text] [Related]  

  • 28. Access to chloroquine in patients with rheumatic and musculoskeletal diseases attending rheumatology outpatient clinics during the COVID-19 pandemic.
    Ntshalintshali SD; Geldenhuys EM; Moosajee F; Musa WAM; Du Plessis L; Viljoen A; Fortuin D; Du Toit R
    S Afr Med J; 2021 Jun; 111(8):720-723. PubMed ID: 35227350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry.
    Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A
    Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Georgiev T
    Rheumatol Int; 2020 May; 40(5):825-826. PubMed ID: 32232552
    [No Abstract]   [Full Text] [Related]  

  • 33. African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic.
    Akintayo RO; Bahiri R; El Miedany Y; Olaosebikan H; Kalla AA; Adebajo AO; Migowa AN; Slimani S; Koussougbo OD; Kawther BA; Akpabio AA; Ghozlani I; Dey D; Hassan WA; Govind N; Makan K; Mohamed A; Genga EK; Ghassem MKA; Mortada M; Hamdi W; Wabi MO; Tikly M; Ngandeu-Singwe M; Scott C
    Clin Rheumatol; 2021 Sep; 40(9):3445-3454. PubMed ID: 32876786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
    Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
    Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.
    Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H
    Z Rheumatol; 2021 Dec; 80(Suppl 2):33-48. PubMed ID: 34491403
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.
    Bansal P; Goyal A; Cusick A; Aslam F
    Arthritis Rheumatol; 2021 Mar; 73(3):547-548. PubMed ID: 33142038
    [No Abstract]   [Full Text] [Related]  

  • 37. Response to: 'Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India' by Goyal
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e72. PubMed ID: 32669304
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 revisiting inflammatory pathways of arthritis.
    Schett G; Manger B; Simon D; Caporali R
    Nat Rev Rheumatol; 2020 Aug; 16(8):465-470. PubMed ID: 32561873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19: a primer for the rheumatologist: management of patients and care settings.
    Calabrese C; Lehman B
    Curr Opin Rheumatol; 2020 Sep; 32(5):429-433. PubMed ID: 32744823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should coronavirus disease 2019 concern rheumatologists?
    Kucharz EJ
    Pol Arch Intern Med; 2020 Aug; 130(7-8):655-661. PubMed ID: 32426957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.